Skip to content

The Mysterious on/Off Itch and Erythema During Whole Body Vibration Exercise

The Mysterious on/Off Itch and Erythema During Whole Body Vibration Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03455036
Acronym
VIBRA
Enrollment
20
Registered
2018-03-06
Start date
2017-12-18
Completion date
2019-06-17
Last updated
2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Itch; Athlete

Keywords

whole body vibration, erythema, tryptase, unpleasantness

Brief summary

Intense itch on the legs sometimes associated with redness can be adverse effects of whole body vibration (WBV) according to own observations and numerous posts in non-professional online-blogs. To the investigators' knowledge, the appearance of itch and/or a rash during WBV exercise has not yet been described. The research objectives are: 1. To determine the effect of WBV on itch rating and its unpleasantness and on skin changes. 2. To determine the effect of WBV on immunoglobulin E (IgE) and serum tryptase

Detailed description

Objectives Intense itch on the legs sometimes associated with redness can be adverse effects of WBV according to the investigators observations and numerous posts in non-professional online-blogs. To the investigators knowledge, the appearance of itch and/or a rash during WBV exercise has not yet been described. The objectives of this study are: 1. to determine the effect of WBV on itch rating and its unpleasantness and on skin changes. 2. to determine the effect of WBV on serum tryptase. Hypothesis The working hypothesis is that repeated WBV leads to an increase of itching and erythema. Further investigators hypothesize that repeated WBV does not lead to an increase in serum tryptase. Inclusion and exclusion criteria will be evaluated. Subjects will be instructed to not shave their legs one week before the intervention day and to shave only the left leg from the ankle to the knee on the day prior to the intervention day. On the intervention day, subjects will be informed in detail about the study protocol and written informed consent will be collected. If a pregnancy cannot be excluded (days from last menstruation) subjects are instructed to do a pregnancy test. Then, a blood sample will be taken. Subsequently, subjects will be instructed to stand on the vibration plate (Galileo 900) in a slightly crouched position with their hands loosely resting on the rail. Subjects will complete ten 1-minute WBV repetitions interspaced by 1-minute breaks in seated position. During each break, subjects will rate the itch intensity, and skin changes will be captured. Sixty minutes after the last WBV repetition, another blood sample will be taken. Subjects will rest until itch and erythema return to baseline. During resting phase subjects will fill in the Eppendorf itch questionnaire and the Erlanger atopy score.

Interventions

OTHERWhole body vibration training

10 x 1 min whole body vibration exposure

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The design of the study is a single-centre cross-sectional single-arm intervention study.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-35 years * female * Informed Consent as documented by signature (Appendix Informed Consent Form)

Exclusion criteria

* itchy skin diseases * hay fever * asthma * chronic venous insufficiency * peripheral artery disease * musculoskeletal diseases or injuries affecting the legs, hips and pelvis * BMI \< 17 and \> 35 kg/m2 * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Itch intensity0 months0 to 10 numerical rating scale (NRS) (best score: 0 - no itch; worst score: 10)

Secondary

MeasureTime frameDescription
Itch characteristics0 monthsmeasured using Eppendorf itch questionnaire
Itch unpleasantness0 months0 to 10 numerical rating scale (NRS) (best score: 0 - no unpleasantness; worst score: 10)
Skin surface temperature0 monthsassessed using a infrared thermal camera
Erlanger atopy score0 monthsErlanger atopy score (best score: 0 - no atopy; worst score: 100)
Total immunoglobulin E (IgE) concentration0 monthsSerum
Tryptase concentration0 monthsserum
Erythema intensity0 monthsassessed using an erythema meter

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026